Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Danone raises sales outlook as shoppers absorb price hikes

Published 26/04/2023, 06:33
© Reuters. FILE PHOTO: A company logo is seen on a product displayed before French food group Danone's 2019 annual results presentation in Paris, France, February 26, 2020. REUTERS/Christian Hartmann/File Photo

By Dominique Vidalon

PARIS (Reuters) -Danone, the world's largest yoghurt-maker, raised its 2023 outlook on Wednesday after it managed to pass on increased costs through price rises and first-quarter sales growth was the fastest in a decade.

Danone, which expects prices to peak this year and also anticipates productivity gains, kept its forecast for a moderate improvement in recurring operating margin for the year.

The maker of Activia yoghurt, Evian water and Aptamil infant milk said it expected like-for-like 2023 sales growth of between 4% and 6%, having previously forecast 3%-5% growth.

Sales rose 10.5% like-for-like to 6.96 billion euros ($7.68 billion) in the first quarter, beating expectations for 7.3% growth in a company-compiled consensus of 18 analysts. This was its fastest quarterly growth rate in a decade.

By 0811 GMT, Danone shares were up 1% at 61.08 euros, outperforming the wider market.

All three of Danone's businesses contributed to growth and Specialised Nutrition and Waters were particularly strong, it said.

Danone increased its prices by 10.3% during the quarter while sales volume remained positive, up 0.2%.

Danone, like its rivals Nestle and Unilever (LON:ULVR), has increased prices to cope with higher commodities and supply chain costs, but faces the challenge of judging how much prices can rise before even affluent shoppers decide to stop buying.

"The story of ever higher prices, with minimal volume impact, continues. Is the sky the limit for our sector’s pricing?" Bernstein analysts asked in a note.

Finance Chief Juergen Esser told analysts that Danone had yet to see a shift in consumer behaviour, but that prices had probably reached a peak and he predicted a "gradual easing through the year".

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In China, Infant Nutrition, and also Adult and Pediatric Specialties made a particularly strong start to the year with double-digit growth.

In Waters, the Mizone brand showed "an encouraging start" as travel conditions improved with the lifting of COVID-19 restrictions, Esser said.

($1 = 0.9063 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.